Can Rheumatoid Arthritis Cause Weight Gain?

Rheumatoid arthritis can contribute to weight gain, but not through the simple mechanism most people imagine. The disease itself, the medications used to treat it, and the lifestyle changes it forces all push weight upward through different pathways. Perhaps more striking, though, is that RA frequently reshapes body composition in ways that standard scales miss entirely: people with RA often lose muscle while gaining fat, a combination that may leave their weight unchanged even as their metabolic health deteriorates.

What Early RA Actually Does to Body Weight

One of the surprises in the research is that early rheumatoid arthritis is at least as likely to cause weight loss as weight gain. A large study of women tracked weight changes around the time RA developed and found that more women with RA lost weight (about 16%) than matched comparators without the disease (about 11%). The proportion who gained weight was nearly identical in both groups: roughly 20% in each, with severe weight gain occurring in only about 2% regardless of RA status.¹ So early in the disease, RA does not reliably cause people to pack on pounds. The systemic inflammation and high energy demands of an active immune response can actually tip the balance toward weight loss in the short term.

That picture changes over time. As RA becomes established and people adjust their activity levels, start medications, and deal with chronic pain, weight gain becomes more common. But the pattern of that gain matters enormously, and it is different from ordinary weight gain in the general population.

The Hidden Shift in Body Composition

The more important story with RA and weight is not what the scale reads but what is happening underneath. RA drives a phenomenon called sarcopenic obesity, where a person loses lean muscle mass while gaining fat tissue. Your weight might stay the same or even drop slightly, yet your body has quietly become less muscular and more fatty. This matters because muscle is metabolically active tissue that helps regulate blood sugar and supports joint function, so losing it while gaining fat is a double hit.

Research consistently shows this pattern is far more common in people with RA than in the general population. One study comparing RA patients to population reference groups found that about 13% of RA patients had sarcopenic obesity, compared to roughly 4% in the general population.² Another study found sarcopenia in half of RA participants, and of those, two-thirds also qualified as having sarcopenic obesity.³ Numbers vary across studies depending on how sarcopenia is defined and which population is examined, but the direction is consistent: RA makes you more likely to lose muscle and gain fat simultaneously.

This matters practically because people with sarcopenic obesity tend to have worse physical function. One study found that RA patients with sarcopenic obesity scored worse on timed physical performance tests and self-reported disability measures than patients who were simply obese or simply sarcopenic.⁴ So even if your weight looks “normal,” the composition shift can leave you weaker and less functional.

There are also sex-based differences in how RA redistributes fat. Research has found that men with RA tend to accumulate more visceral fat (the deep abdominal fat surrounding organs) than men without the disease, while women with RA tend to accumulate more subcutaneous fat, even when overall BMI and waist circumference look similar between groups.⁵ These patterns carry different cardiovascular risks and partly explain why standard BMI measurements are unreliable indicators of metabolic health in RA.

How RA Medications Drive Weight Gain

If RA itself sends mixed signals on the scale, the medications used to treat it often tip the balance clearly toward weight gain. Glucocorticoids (steroids like prednisone and prednisolone) are the most obvious culprit. They increase appetite, promote fat storage in the trunk and abdomen, and break down muscle and bone to fuel liver glucose production. Even at low doses used in RA management, the effect on weight is real and measurable.

A pooled analysis of individual patient data from five randomized trials found that low-dose glucocorticoids led to about 1 kg more weight gain than control treatments over two years.⁶ That may sound modest, but data from a separate randomized trial showed that nearly 30% of patients on prednisolone gained more than 2 kg over two years, compared to 18% on placebo.⁷ There is a nuance worth noting from that same trial: the weight gained on prednisolone was not purely fat. Patients actually showed favorable shifts in body composition, with lean mass increases exceeding fat mass increases and significant gains in appendicular lean mass. So the steroid effect on weight is not as straightforwardly harmful as people often assume.

An earlier study of prednisolone-naive early RA patients found that steroid-treated patients gained about 1.6 kg of total body mass and 1.3 kg of fat mass over six months, with the prevalence of overweight in the group climbing to 50%.⁸

Biologic therapies, particularly TNF-alpha inhibitors like infliximab, etanercept, and adalimumab, also appear to promote some weight gain. A systematic review and meta-analysis found that patients gained, on average, about 1 to 2.3 kg during treatment, with the amount varying by specific drug.⁹ The theory here is that TNF-alpha is a cytokine involved in both inflammation and energy expenditure, so blocking it may reduce the body’s caloric burn. However, a smaller study that compared TNF-inhibitor patients directly to non-TNF-inhibitor patients found no statistically significant difference in weight gain between the groups over two years, suggesting the gain may partly reflect disease improvement and appetite recovery rather than a direct drug effect.¹⁰

Pain, Fatigue, and the Activity Gap

Beyond medication, RA quietly drives weight gain through reduced physical activity. Joint pain, stiffness, and the crushing fatigue that accompanies active disease make it harder to move. Research measuring total energy expenditure found that it was inversely associated with disease activity and fatigue levels: the more active the disease and the more fatigued the person, the less energy they burned.¹¹ Over months and years, this activity gap adds up. You eat roughly the same amount (or possibly more, since some medications increase appetite), but you move less. The caloric surplus gets stored as fat, often while muscle atrophies from disuse.

There is also an emotional dimension. A study comparing eating behaviors in RA patients found that emotional eating scores were significantly higher among obese RA patients compared to non-obese RA patients. Living with chronic pain and reduced function creates stress, and for some people, food becomes a coping mechanism. The combination of medication-driven appetite increases, reduced activity, and emotional eating creates a reinforcing cycle that can be difficult to break.

Why Being Overweight Makes RA Worse

The relationship between RA and weight runs in both directions. Excess weight does not just happen alongside RA; it actively makes the disease harder to manage. Obese individuals with RA tend to have higher disease activity, more pain, worse self-reported health, and lower rates of sustained remission.¹² Fat tissue is not metabolically inert; it produces inflammatory cytokines and adipokines that can amplify the immune dysfunction already present in RA.¹³

This creates a frustrating feedback loop. RA and its treatments promote weight gain, and that weight gain in turn fuels more inflammation and makes the disease harder to control. Breaking the cycle is possible, but it requires attention to both disease management and weight management simultaneously.

The gut microbiome may also play a connecting role. Researchers found that obesity was more common in RA patients than in controls (about 36% versus 25%), and that obese RA patients had distinct gut bacteria profiles, including expansion of a genus called Dialister. Higher disease activity was itself associated with greater odds of obesity, suggesting the inflammatory state of RA may alter gut flora in ways that promote fat storage.¹⁴

How Weight Affects Treatment Response

Your body weight can also influence how well your RA medications work, particularly TNF inhibitors. One study found that patients who failed to achieve low disease activity on TNF inhibitors had a significantly higher average BMI (about 29) than those who responded well (about 25). Interestingly, this effect was not seen with tocilizumab, a biologic targeting a different inflammatory pathway, where BMI made no difference in response rates.¹⁵ A separate study confirmed that BMI did not affect response to tocilizumab, with similar outcomes across weight categories.¹⁶

The reason likely comes down to how TNF inhibitors interact with fat tissue. Adipose tissue produces TNF-alpha independently of the joints, so in an obese person, there is more inflammatory TNF-alpha to neutralize, potentially overwhelming the standard drug dose. Tocilizumab targets interleukin-6 instead and appears less sensitive to this problem. If you have RA and are struggling with treatment response while carrying extra weight, this is worth discussing with your rheumatologist, since switching drug classes may produce better results than dose escalation alone.

Weight Loss and Disease Improvement

The encouraging news is that losing weight can meaningfully improve RA disease activity. A retrospective study found that overweight or obese RA patients who lost at least 5 kg had roughly three times the odds of disease activity improvement compared to those who did not lose weight.¹⁷ Each kilogram lost was associated with a meaningful reduction in a standard disease activity score. Reviews of the evidence also suggest that weight loss following bariatric surgery decreases RA disease activity and improves remission rates, though the evidence from diet-based weight loss is more limited and has not been confirmed in large randomized controlled trials.¹⁸

A randomized trial tested a structured program combining supervised weight loss and exercise training against basic lifestyle counseling in older adults with RA. The structured program significantly improved body weight, fat mass, disease activity scores, physical function, fatigue, and both physical and mental health compared to counseling alone.¹⁹ When the researchers teased apart which components mattered most, they found that weight loss was most strongly tied to improvements in cardiovascular risk and mental health, aerobic training was most tied to physical function and fatigue reduction, and resistance training was most tied to disease activity reduction. All three components contributed, but through different pathways.

Resistance Training and Muscle Preservation

Given that RA promotes muscle loss alongside fat gain, exercise that specifically builds or preserves muscle is especially valuable. A randomized controlled trial of high-intensity resistance training in RA patients found that it increased lean body mass and appendicular lean mass, reduced trunk fat by about 2.5 kg, and improved strength dramatically: training-specific strength went up by 119%, chair-stand performance by 30%, and walking speed by 17%. Patients in the control group showed no changes in body composition or function over the same period.²⁰

This is meaningful because it shows that the muscle loss seen in RA is not inevitable. Even high-intensity training, which many RA patients might assume would worsen their joints, produced major functional gains. The key is working with physical therapists or trainers who understand the disease and can adapt programming to protect inflamed joints while still providing enough stimulus to build muscle.

Dietary Patterns and Inflammation

Anti-inflammatory diets, particularly Mediterranean-style eating patterns, have attracted interest for RA management. A randomized feeding trial found that a Mediterranean diet reduced disease activity scores by about 76% more than a low-fat, high-carbohydrate diet over 12 weeks, though the weight loss between the two groups was not significantly different.²¹ This suggests that what you eat may matter independently of how much weight you lose, likely because the anti-inflammatory compounds in a Mediterranean diet (omega-3 fats, polyphenols, fiber) help dampen the immune overactivation of RA.

A crossover trial of an anti-inflammatory diet in RA patients found some effects on disease activity but no significant weight changes during either the intervention or control diet periods.²² So anti-inflammatory diets may help with RA symptoms without necessarily producing weight loss on their own. If weight management is the goal, caloric restriction or structured programs still seem necessary alongside the dietary pattern shift.

Cardiovascular Risk and Weight Swings

For people with RA who are managing their weight, it is worth knowing that the pattern of weight change matters, not just the direction. A study of cardiovascular events in RA patients found that both significant weight loss (10% or more) and significant weight gain carried increased cardiovascular risk, with hazard ratios of about 1.18 and 1.20 respectively. The association was even stronger in patients who started with a normal BMI. Greater variability in weight over time, the yo-yo pattern of losing and regaining, was independently tied to higher cardiovascular event risk.²³

The relationship between BMI and cardiovascular outcomes in RA is also more complicated than in the general population. A study found that the interaction between BMI and heart risk depended on both the type of antibodies present in the disease and whether the patient was on biologic therapy. Among a specific subgroup of patients (those without anti-citrullinated protein antibodies who were on biologic DMARDs), higher BMI was actually associated with lower cardiovascular risk, a pattern that ran opposite to what you would expect in the general population.²⁴ This does not mean weight gain is protective in RA, but it does mean that simplistic BMI-based risk calculations borrowed from the general population can be misleading for RA patients. The chronic inflammation of RA changes the rules in ways researchers are still sorting out.

The practical takeaway for weight management in RA is that gradual, sustained weight loss through a combination of dietary changes and appropriate exercise is the safest approach. Crash diets and rapid weight cycling are risky for anyone but may carry additional cardiovascular danger in RA. Aim for steady changes, preserve muscle with resistance training, and work with your care team to adjust medications if weight gain becomes a persistent problem.